Elanco Animal Health Incorporated (ELAN) — closed signal from September 5, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on December 4, 2025.
Predicted vs. what happened
What happened
Reached its target in 26 days.
The thesis — published September 5, 2025
Short term, this looks like a mood-driven bounce idea. Sales last quarter beat expectations, and the stock was added to a major mid-size index, which can bring automatic buying from investment funds. A rival's new vaccine pushed the price down, which could be a better entry. The risk is how well Elanco executes and handles competition. Over the next 0-3 months, these positives could help the price recover if buying shows up.
Primary drivers
- Last quarter's sales came in higher than expected, lifting confidence.
- Now part of a major mid-size stock index, inviting fund buying.
- Price looked washed out and the recent average price trend is turning up.
- A rival launched a vaccine, adding competition that could pressure results.
How it played out
ELAN: target reached in 26 days
Lyra published ELAN at $17.97 on 2025-09-05 as a short-term bounce thesis. The expected gain was 16%. The thesis pointed to better-than-expected sales last quarter, index inclusion that could bring fund buying, a washed-out price with the recent average trend turning up, and competition from a rival vaccine as the main risk.
Inside the window, the stock reached the $20.84 target in 26 days. It kept rising and peaked at $23.7 on 2025-11-26, a 31.9% gain. By 2025-12-04, it ended at $21.99. The published thesis played out and then went beyond the target.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.